Abbott receives fda approval for tactiflex™ ablation catheter for treatment of abnormal heart rhythm

Tactiflex™ ablation catheter, sensor enabled™, is the world's first ablation catheter designed with a unique flexible electrode tip and contact force sensing to treat patients with atrial fibrillation when used with abbott's ensite™ x ep system, physicians have better visualization allowing for more accuracy and precision with the tactiflex catheter, leading to reduced procedure times and better safety abbott park, ill., may 19, 2023 /prnewswire/ -- abbott (nyse: abt) today announced that the u.s. food and drug administration (fda) has approved the company's tactiflex™ ablation catheter, sensor enabled™, the world's first ablation catheter with a flexible tip and contact force technology.
ABT Ratings Summary
ABT Quant Ranking